Cargando…
Apocynin, a Low Molecular Oral Treatment for Neurodegenerative Disease
Accumulating evidence suggests that inflammatory mediators secreted by activated resident or infiltrated innate immune cells have a significant impact on the pathogenesis of neurodegenerative diseases. This may imply that patients affected by a neurodegenerative disease may benefit from treatment wi...
Autores principales: | ‘t Hart, Bert A., Copray, Sjef, Philippens, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129132/ https://www.ncbi.nlm.nih.gov/pubmed/25140304 http://dx.doi.org/10.1155/2014/298020 |
Ejemplares similares
-
Apocynin: Molecular Aptitudes
por: Stefanska, J., et al.
Publicado: (2008) -
Improvement of Pharmacokinetics Behavior of Apocynin by Nitrone Derivatization: Comparative Pharmacokinetics of Nitrone-Apocynin and its Parent Apocynin in Rats
por: Wang, Kaiyu, et al.
Publicado: (2013) -
Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson’s Disease
por: Peng, Su-Ping, et al.
Publicado: (2015) -
Induced Pluripotent Stem Cell Technology and Direct Conversion: New Possibilities to Study and Treat Parkinson’s Disease
por: Roessler, Reinhard, et al.
Publicado: (2012) -
Dynamic Changes in Ezh2 Gene Occupancy Underlie Its Involvement in Neural Stem Cell Self-Renewal and Differentiation towards Oligodendrocytes
por: Sher, Falak, et al.
Publicado: (2012)